Press Releases

  • Aug. 10, 2011 biOasis announces completion of acquisition of Intellectual Property

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V:BTI) (the “Company”) announces that its wholly owned subsidiary biOasis Advanced Technologies Inc. (“BAT”) has completed the acquisition of certain Intellectual Property pursuant to a Worldwide Assignment dated June 16, 2011 on terms as previously disclosed. On August 5, 2011, the closing date, the Company paid $25,000 in cash… Read more »

  • Aug. 5, 2011 biOasis announces acquisition of Intellectual Property

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V:BTI) (the “Company”) announces that its wholly owned subsidiary biOasis Advanced Technologies Inc. has entered into a worldwide assignment (the “Assignment”) to acquire certain Intellectual Property. Pursuant to the Assignment, the Company will pay $25,000 in cash and will issue 350,000 warrants at an exercise price of $0.575 and… Read more »

  • Jul. 6, 2011 biOasis Announces Transcend Vector Results with a Therapeutic Antibody That Targets Metastatic Breast Cancer

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V:BTI) today announced results from two studies designed to assess the therapeutic potential of its Transcend vector in treating metastatic breast cancer. In these studies trastuzumab (tradename Herceptin®), a humanized monoclonal antibody used clinically in the treatment of HER2-positive (“HER2+”) breast cancer, was chemically linked to the Transcend delivery… Read more »

  • Jun. 24, 2011 biOasis Director Resigns

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V:BTI) announces that Mr. David Howard has resigned from the board of directors and audit committee. Mr. Howard has been a member of the board since August 9th, 2010. “We would like to thank David for his valuable contribution and service on the board of directors of the Company,”… Read more »

  • Jun. 23, 2011 biOasis to Present on Drug Delivery at International Conference on Cerebral Vascular Biology

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX:V BTI) is pleased to announce that it will be presenting data on its Transcend technology for delivery of drugs into the brain at the 9th annual International Conference on Cerebral Vascular Biology being held in Leiden Netherlands from June 21-25th 2011. Dr. Reinhard Gabathuler, biOasis VP of… Read more »

  • May. 12, 2011 biOasis Initiates Transcend Vector Program Targeting Treatments for CNS Symptoms of Lysosomal Storage Disorders

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX:V.BTI) announced today the initiation of its first Transcend therapeutic development program directed towards developing treatments for the neurological effects of lysosomal storage disorders (“LSD”). This strategic decision is based on recently announced results from the National Research Council of Canada demonstrating that intravenously administered Transcend is delivered… Read more »

  • May. 3, 2011 biOasis Receives Verification That Transcend Localizes To a Number of Cell Types in the Brain

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX:V BTI) has received further experimental results from research performed on behalf of the Company by the National Research Council of Canada (“NRC”). This work was performed for the purpose of providing independent confirmation of results generated in prior work conducted by the Company. As reported previously, the… Read more »

  • Apr. 19, 2011 biOasis Adds MarketSmart Communications Inc. to Investor Relations Team

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX:V BTI) is pleased to announce it has entered into a consulting agreement (“Agreement”) for MarketSmart Communications Inc (“MarketSmart”) to provide investor relations services to the Company. MarketSmart was established in 2002 and President, Maria Da Silva has worked with many TSX Venture Exchange companies to assist in… Read more »

  • Apr. 15, 2011 biOasis Receives Significant Independent Results From its Transcend Program

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX:V BTI) has received experimental results from research performed on behalf of the Company by the National Research Council of Canada (“NRC”). This work was performed for the purpose of providing independent confirmation of results generated in prior work conducted by the Company. The NRC study used the… Read more »

  • Apr. 14, 2011 biOasis Director Resigns

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX:V BTI) announces that Mr. George Sanders has resigned from the board of directors for personal reasons. Mr Sanders has been a member of the board since February 14, 2007. “We would like to thank George for his valuable contribution and service on the board of directors of… Read more »